Article
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
21 May 2020
Abstract excerpt
Temozolomide (TMZ) resistance is a complication of treatment of glioma, and new strategies are urgently required to overcome chemoresistance in glioma cells. In the present study, it was demonstrated that tripartite motif‑containing 31 (TRIM31) was abnormally upregulated in glioma tissues and cell lines compared with normal samples. Furthermore, the role of TRIM31 was assessed by overexpressing and knocking down...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
